- Home
- DOYU vs BWAY Comparison
DOYU vs BWAY Comparison
Compare DOYU & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOYU
- BWAY
- Stock Information
- Founded
- DOYU 2014
- BWAY 2003
- Country
- DOYU China
- BWAY Israel
- Employees
- DOYU N/A
- BWAY N/A
- Industry
- DOYU Computer Software: Programming Data Processing
- BWAY Medical/Dental Instruments
- Sector
- DOYU Technology
- BWAY Health Care
- Exchange
- DOYU Nasdaq
- BWAY Nasdaq
- Market Cap
- DOYU 246.3M
- BWAY 280.7M
- IPO Year
- DOYU 2019
- BWAY 2019
- Fundamental
- Price
- DOYU $7.89
- BWAY $15.55
- Analyst Decision
- DOYU Hold
- BWAY Strong Buy
- Analyst Count
- DOYU 1
- BWAY 2
- Target Price
- DOYU $7.00
- BWAY $18.00
- AVG Volume (30 Days)
- DOYU 83.0K
- BWAY 91.5K
- Earning Date
- DOYU 08-18-2025
- BWAY 08-13-2025
- Dividend Yield
- DOYU 243.48%
- BWAY N/A
- EPS Growth
- DOYU N/A
- BWAY 515.14
- EPS
- DOYU N/A
- BWAY 0.11
- Revenue
- DOYU $586,290,301.00
- BWAY $46,084,000.00
- Revenue This Year
- DOYU N/A
- BWAY $339.49
- Revenue Next Year
- DOYU N/A
- BWAY $21.74
- P/E Ratio
- DOYU N/A
- BWAY $55.73
- Revenue Growth
- DOYU N/A
- BWAY 26.50
- 52 Week Low
- DOYU $5.68
- BWAY $7.36
- 52 Week High
- DOYU $16.99
- BWAY $16.25
- Technical
- Relative Strength Index (RSI)
- DOYU 49.96
- BWAY 67.34
- Support Level
- DOYU $7.69
- BWAY $15.32
- Resistance Level
- DOYU $8.19
- BWAY $16.25
- Average True Range (ATR)
- DOYU 0.44
- BWAY 0.59
- MACD
- DOYU -0.00
- BWAY -0.07
- Stochastic Oscillator
- DOYU 50.00
- BWAY 71.95
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.